Transthyretin Cardiac Amyloidosis
📧 Sign up to get email alerts when something new happens for Transthyretin Cardiac Amyloidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Prevalence of wtATTR-CM After Carpal Tunnel Release Surgery [NA]
A completed clinical trial evaluating the prevalence of wild-type transthyretin cardiac amyloidosis after carpal tunnel release surgery.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis [EARLY_Phase 1]
An early-phase Phase 1 study evaluated the prevalence of transthyretin cardiac amyloidosis among patients with clinically significant aortic…
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: A Study of Doxycycline and Tauroursodeoxycholic Acid (Doxy/TUDCA) Plus Standard Supportive Therapy Versus Standard Supportive Therapy Alone in Cardiac Amyloidosis Caused by Transthyretin [Phase 3]
A Phase 3 trial comparing doxycycline plus tauroursodeoxycholic acid (Doxy/TUDCA) with standard supportive therapy versus standard therapy a…
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: Phase 2 Study to Evaluate ALN-TTRSC (Revusiran) in Patients With Transthyretin (TTR) Cardiac Amyloidosis [Phase 2]
Phase 2 study evaluating ALN-TTRSC (Revusiran) in patients with transthyretin cardiac amyloidosis has completed.